Independent Medical Grants and Donations

Pfizer supports the submission of grant requests from healthcare organisations to support the independent medical and/or scientific initiatives of that healthcare organisation, that are aligned to Pfizer's medical and/or scientific strategies.


Quality Improvement (QI) and Independent Medical Education (IME) Calls for Proposals

Listed below are the ‘QI and IME Calls’ that are currently open to UK Healthcare and Research Organisations and Institutions. Dependent on the nature of the call, some are available through a competitive review process and others on a 'first come, first served' basis. Both types are subject to any stated criteria and available capacity:


Bespoke Grant Requests

The broad therapy areas that Pfizer is currently working within include: Inflammation and Immunology, Internal Medicine, Oncology, Rare Diseases, Hospital (anti-microbials) and Vaccines.


To find out more about the application types and process, download our PDF guides below:

Examples may include grant requests to support independent accredited education, quality improvement or research that are intended to improve patient outcomes in areas of unmet medical need.

For all independent medical grants, the grant recipient is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Pfizer must not be involved in any aspect of project development, nor its conduct or monitoring.

To discuss your potential independent medical grant application for any of the above areas, please phone 01304 616161 and ask to speak to a member of the medical affairs team.


Types of Independent Medical Grant applications that Pfizer UK may consider:


Quality Improvement Grant

This type of medical grant is Pfizer funding to support independent projects for systematic and continuous actions that lead to measurable improvement in health care services and the health status of individuals and targeted patient groups and do not relate to a Pfizer asset. Quality improvement considers aspects of quality such as clinical competence, outcomes and process assessment, programme evaluation, quality indicators, and quality assurance using methodologically rigorous protocols with an endpoint goal of readiness for application to practice.

See Pfizer’s Key Contractual Terms and Conditions here.


Independent Medical Education (IME) Grant

This type of medical grant is Pfizer funding to support independent accredited medical education activities or initiatives which serve to maintain, develop, or increase the knowledge, skills, and/or professional performance of a healthcare professional (e.g. continuing medical education, continuing health education, continuing education).

See Pfizer’s Key Contractual Terms and Conditions here.


General Research Grant

This type of medical grant is Pfizer funding to support a general research project focused on the development or refinement of specific and defined medical knowledge that does not include the study of a Pfizer asset. It includes health services research, registry development and/or queries and outcomes research unrelated to a Pfizer asset.

See Pfizer’s Key Contractual Terms and Conditions here.


Types of Independent Medical Grants that Pfizer Inc. may consider:


Investigator Sponsored Research (ISR)

This is a type of medical grant that supports an independent research study where the investigator and / or organisation is the sponsor of the study and where Pfizer provides financial and/or non-financial support for the development or refinement of specific and defined medical knowledge relating to a Pfizer asset.

This global programme is open to all researchers who are interested in conducting their own research. This grant type is used as support for pre-clinical and clinical studies (including interventional and non-interventional), that involve a Pfizer asset.


Global Competitive Grants Programme

This involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest, sets timelines for review and approval, and uses a review panel (Either Internal Review Panel or External Review Panel depending on the nature of the call) to make final grant decisions. Healthcare Organisations are invited to apply where their application addresses specific gaps in research, practice or care as outlined in the specific RFP. Please note that all RFPs may not be open to applications from UK Healthcare Organisations.

View Frequently Asked Questions regarding the Competitive Grant Programme.


PP-PFE-GBR-4167 / November 2021